Beacon Investment Advisory Services Inc. Grows Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Beacon Investment Advisory Services Inc. increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.1% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 71,243 shares of the medical equipment provider’s stock after buying an additional 99 shares during the period. Intuitive Surgical accounts for about 1.5% of Beacon Investment Advisory Services Inc.’s holdings, making the stock its 22nd largest holding. Beacon Investment Advisory Services Inc.’s holdings in Intuitive Surgical were worth $35,000,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in ISRG. Benjamin Edwards Inc. grew its stake in shares of Intuitive Surgical by 148.7% in the third quarter. Benjamin Edwards Inc. now owns 13,673 shares of the medical equipment provider’s stock worth $6,718,000 after acquiring an additional 8,176 shares during the period. Paloma Partners Management Co grew its position in Intuitive Surgical by 2,305.5% in the 3rd quarter. Paloma Partners Management Co now owns 4,811 shares of the medical equipment provider’s stock worth $2,364,000 after purchasing an additional 4,611 shares during the period. Point72 Asia Singapore Pte. Ltd. purchased a new stake in Intuitive Surgical during the 3rd quarter valued at $1,070,000. Kestra Investment Management LLC bought a new position in shares of Intuitive Surgical during the 3rd quarter valued at $380,000. Finally, Point72 Hong Kong Ltd purchased a new position in shares of Intuitive Surgical in the 3rd quarter worth $4,397,000. Institutional investors own 83.64% of the company’s stock.

Analyst Ratings Changes

ISRG has been the subject of a number of research reports. JPMorgan Chase & Co. upped their price objective on Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. Leerink Partners upped their price target on shares of Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. Evercore ISI reissued a “cautious” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Finally, Stifel Nicolaus boosted their price objective on shares of Intuitive Surgical from $475.00 to $525.00 and gave the company a “buy” rating in a research report on Friday, October 18th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $536.61.

Insider Activity

In other Intuitive Surgical news, Director Amy L. Ladd sold 450 shares of the firm’s stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $490.28, for a total value of $220,626.00. Following the completion of the sale, the director now owns 821 shares of the company’s stock, valued at $402,519.88. This trade represents a 35.41 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Jamie Samath sold 22,903 shares of the business’s stock in a transaction on Friday, November 8th. The shares were sold at an average price of $525.00, for a total value of $12,024,075.00. Following the transaction, the insider now owns 8,757 shares of the company’s stock, valued at approximately $4,597,425. The trade was a 72.34 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 50,459 shares of company stock valued at $26,080,251 in the last ninety days. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Trading Up 0.6 %

NASDAQ:ISRG opened at $542.00 on Monday. The company has a market capitalization of $193.05 billion, a P/E ratio of 87.14, a P/E/G ratio of 5.33 and a beta of 1.39. The business’s 50-day moving average is $510.03 and its 200 day moving average is $469.49. Intuitive Surgical, Inc. has a 12 month low of $304.50 and a 12 month high of $552.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. The business had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. On average, research analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.